Diametica Therapeutics, Inc.(DMAC)
Biotechnology company
1 Insight
Investment Insights
AI-generated insights about Diametica Therapeutics, Inc. from various financial sources
Monday, September 8, 2025
Very Bullish
Multiple insiders with a good track record are making unusually large purchases, with a 10% owner increasing his holdings by over 50% ($11 million in six weeks), signaling strong confidence.
Monday, September 8, 2025
Very Bullish
Multiple insiders with a good track record are making unusually large purchases, with a 10% owner increasing his holdings by over 50% ($11 million in six weeks), signaling strong confidence.